Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Guangyu Chen

Matched on ORCID iD 0000-0003-2873-640X; OpenAlex author ID A5100654881. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2020: 3 papers · 2021: 6 papers · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 14

  1. Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context graph model. Co-author DOI 10.1016/j.canlet.2025.217751↗
  2. FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. Co-author DOI 10.1158/0008-5472.can-23-3638↗
  3. Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer. Co-author DOI 10.1007/s13402-023-00836-3↗
  4. Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. Co-author DOI 10.1093/bjs/znac375↗
  5. HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway. Co-author DOI 10.1002/mc.23420↗
  6. CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13402-020-00569-7↗
  7. Targeting hypoxic tumor microenvironment in pancreatic cancer. Co-author DOI 10.1186/s13045-020-01030-w↗
  8. Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.709669↗
  9. Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.596573↗
  10. The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells. Co-author DOI 10.3390/cells10030497↗
  11. Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis. Last author DOI 10.3892/etm.2021.10576↗
  12. The enhancement of glycolysis regulates pancreatic cancer metastasis. Co-author DOI 10.1007/s00018-019-03278-z↗
  13. Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory. Co-author DOI 10.1186/s12935-020-1147-9↗
  14. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Co-author DOI 10.1186/s12943-020-01169-7↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Taiping Zhang · 12 shared papers, 2020–2025 · strength 1.71
  2. Gang Yang · 12 shared papers, 2020–2025 · strength 1.65
  3. Fangyu Zhao · 10 shared papers, 2020–2023 · strength 1.29
  4. Lei You · 9 shared papers, 2020–2025 · strength 1.17
  5. Jinxin Tao · 7 shared papers, 2021–2025 · strength 1.13
  6. Yupei Zhao · 8 shared papers, 2020–2023 · strength 1.04
  7. Yueze Liu · 7 shared papers, 2020–2024 · strength 1.00
  8. Jiangdong Qiu · 6 shared papers, 2021–2025 · strength 0.89
  9. Jiangdong Qiu · 5 shared papers, 2020–2024 · strength 0.70
  10. Wenhao Luo · 5 shared papers, 2020–2024 · strength 0.66
  11. Zhe Cao · 4 shared papers, 2020–2023 · strength 0.50
  12. Jianchun Xiao · 3 shared papers, 2021–2023 · strength 0.40
  13. Jinshou Yang · 3 shared papers, 2020–2021 · strength 0.35
  14. Dan Su · 2 shared papers, 2022–2023 · strength 0.31
  15. Hua Huang · 2 shared papers, 2021–2023 · strength 0.28
  16. Bo Ren · 2 shared papers, 2020 · strength 0.23
  17. Bo Xu Ren · 1 shared paper, 2025 · strength 0.21
  18. Hao Chen · 1 shared paper, 2025 · strength 0.21
  19. Xinqi Li · 1 shared paper, 2025 · strength 0.21
  20. Jin Gu · 1 shared paper, 2025 · strength 0.21
  21. Yu-Pei Zhao · 1 shared paper, 2025 · strength 0.21
  22. Ruobing Wang · 1 shared paper, 2024 · strength 0.20
  23. Yuanyang Wang · 1 shared paper, 2024 · strength 0.20
  24. Dan Su · 1 shared paper, 2024 · strength 0.20
  25. Gang Yang · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.